GL1X · GenesisL1 explorer

MolNFT v1 · #87087 · protein

KD1 of human tfpi in complex with a synthetic peptide

4BQD · Tissue factor pathway inhibitor (lipoprotein-associated…: “KD1 of human tfpi in complex with a synthetic peptide”. X-ray diffraction, 1 ligand (ACE). MolNFT v1 #87087 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4BQD
Type
protein
Length
183 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) variant…
UniProt
Q59EE5
Ligands
ACE

Structure

x-ray diffraction · 3 distinct chains · 20% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) variantprotein7815% helix, 31% strandQ59EE5
BTissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) variantprotein6518% helix, 25% strandQ59EE5
C, DPeptideprotein2040% helix, 15% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · 2 copies · chains A, C, B, D
  • GOL · Glycerol · additive · 2 copies · chains B, D, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

4 interfaces between chains.

  • A–C · 884 Ų buried · 11 hydrogen bonds · protein-protein
  • B–D · 759 Ų buried · 11 hydrogen bonds · protein-protein
  • A–D · 106 Ų buried · 2 hydrogen bonds · protein-protein
  • A–B · 58 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 2 modified (disulfide, nonstandard).

Compared structures

  • 4BQD · KD1 of human TFPI in complex with a synthetic peptide · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.